You suggest BoD greed on the assumption that their respective remuneration packages are based solely on attendance at meetings, once or twice a month.

I state that this assertion is totally without fact and would firstly suggest that you familiarize yourself with the statutory obligations for non-executive directors and, secondly, read the 10-K's from 2000 onwards.

Here's a clue as to what to look for, taken from 1998:

No direct or indirect remuneration has been paid or is payable by the Company to the directors in their capacity as directors other than the granting of stock options. It is anticipated that during the next twelve months the Company will not pay any direct or indirect remuneration to any directors of the Company in their capacity as directors other than in the form of stock option grants or the reimbursement of expenses of attending directors' or committee meetings.

Why did I invest?

I checked out the patents, dollar signs flashed in front of my eyes, the quantity of stock purchased was highly influenced by the dollar signs, the price went on a roller-coaster ride, I stayed invested without selling any shares because I had set a minimum review price at which I would consider selling, in a word, GREED.

The only difference is that I don't blame the BoD for delays outwith their control, nor do I have a problem with them removing S&L or the terms, as it was what I had hoped they would do, and the sooner the better. GREED got me here, GREED keeps me here, and with every new licensee/USPTO update the pragmatist in me sees an increasing justification for my GREED.

It's a less a question of supporting the BoD but more of proctecting my investment.

Bring on the FUD, I'll still be here.

.

.

Be well